Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

By Elgendy M   Afnan M  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2382-2385

Oxford University Press

Access to resources Recommend Favorite

Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial

By Baart Esther B.   Martini Elena   Eijkemans Marinus J.   Van Opstal Diane   Beckers Nicole G.M.   Verhoeff Arie   Macklon Nicolas S.   Fauser Bart C.J.M.  

Human Reproduction, Vol. 22, Iss. 4, 2007-04 ,pp. : 980-988

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Ovarian hyperstimulation syndrome and benign intracranial hypertension in pregnancy after in-vitro fertilization and embryo transfer: Case report

By Lesny P.  

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1953-1955

Oxford University Press

Access to resources Recommend Favorite

Changes in CA602 and CA546 concentrations in patients during in-vitro fertilization and embryo transfer, and ovarian hyperstimulation syndrome.

By Takamatsu K   Kasuga M   Nakano M   Udagawa Y   Yoshimura Y   Nozawa S  

Human Reproduction, Vol. 12, Iss. 3, 1997-03 ,pp. : 441-445

Oxford University Press

Access to resources Recommend Favorite

Colour Doppler assessment of ascendent uterine artery perfusion in an in-vitro fertilization-embryo transfer programme after pituitary desensitization and ovarian stimulation with human recombinant follicle stimulating hormone.

By Bloechle M   Schreiner T   Küchler I   Schürenkämper P   Lisse K  

Human Reproduction, Vol. 12, Iss. 8, 1997-08 ,pp. : 1772-1777

Oxford University Press

Access to resources Recommend Favorite